|
NUB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.801800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.599200E-03 |
| Normal-vs-Stage2 |
1.123170E-01 |
| Normal-vs-Stage3 |
1.990620E-01 |
| Normal-vs-Stage4 |
4.609400E-01 |
| Stage1-vs-Stage2 |
8.232400E-01 |
| Stage1-vs-Stage3 |
5.018800E-01 |
| Stage1-vs-Stage4 |
4.653600E-01 |
| Stage2-vs-Stage3 |
7.419000E-01 |
| Stage2-vs-Stage4 |
5.773800E-01 |
| Stage3-vs-Stage4 |
7.746600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.203940E-03 |
| Normal-vs-AfricanAmerican |
3.498300E-02 |
| Normal-vs-Asian |
4.840400E-01 |
| Caucasian-vs-AfricanAmerican |
3.903600E-01 |
| Caucasian-vs-Asian |
9.415200E-01 |
| AfricanAmerican-vs-Asian |
8.324600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.184690E-03 |
| Normal-vs-Female |
6.160600E-03 |
| Male-vs-Female |
9.755400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.823800E-01 |
| Normal-vs-Extreme_Weight |
4.939500E-03 |
| Normal-vs-Obese |
8.034800E-04 |
| Normal-vs-Extreme_Obese |
9.286800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.882300E-02 |
| Normal_Weight-vs-Obese |
1.633520E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.828000E-01 |
| Extreme_Weight-vs-Obese |
7.827600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.419200E-01 |
| Obese-vs-Extreme_Obese |
9.833900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.180700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.372000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.662300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.998200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.120000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.405150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.264200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.739600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.967800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.175000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.49390000003802E-06 |
| Normal-VS-Type2 PRCC |
7.878600E-01 |
| Normal-VS-KIRP CIMP |
3.517800E-02 |
| Normal-VS-Unclassified PRCC |
3.557600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.39470000051867E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.737400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.022200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.698100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.400100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.054400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.053000E-01 |
| Normal-vs-N1 |
1.139820E-01 |
| Normal-vs-N2 |
8.429400E-01 |
| N0-vs-N1 |
2.127600E-01 |
| N0-vs-N2 |
9.575400E-01 |
| N1-vs-N2 |
5.468000E-01 |
|
|
